Delivery Order SPE2DB24D2106-SPE2DB25FAWPQ

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,745.97 by the Defense Logistics Agency (DLA) on September 19, 2025. The delivery order, which carries no set-aside designation, covers the supply of Yuvafem 10 microgram vaginal inserts (18 units) with performance at the company's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 22, 2025. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $499.999 billion through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.

This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its long-standing partnership with the DLA to distribute specialized pharmaceutical products to military health facilities. The company's federal contract portfolio demonstrates consistent success in securing diverse pharmaceutical deliveries ranging from contraceptive devices to specialty medications without specific set-aside designations, underscoring its competitive position in federal procurement markets as a woman-owned small business contractor.